Page last updated: 2024-11-04

sumatriptan and Headache

sumatriptan has been researched along with Headache in 149 studies

Sumatriptan: A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.
sumatriptan : A sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used (in the form of its succinate salt) for the acute treatment of migraine with or without aura in adults.

Headache: The symptom of PAIN in the cranial region. It may be an isolated benign occurrence or manifestation of a wide variety of HEADACHE DISORDERS.

Research Excerpts

ExcerptRelevanceReference
"Post-treatment with ketorolac was more effective in attenuating PACAP38-induced headache compared to sumatriptan."9.34Investigation of sumatriptan and ketorolac trometamol in the human experimental model of headache. ( Al-Karagholi, MA; Amin, FM; Arngrim, N; Ashina, M; Ghanizada, H; Larsson, HBW; Metcalf-Clausen, M; Mørch-Rasmussen, M, 2020)
"Cilostazol induced a mild to moderate headache in all but 3 participants (Range 0-7 on Numerical Rating Scale)."9.27Pre-treatment with sumatriptan for cilostazol induced headache in healthy volunteers. ( Falkenberg, K; Olesen, J, 2018)
"Use of sumatriptan improved the quality of recovery as measured by the QoR-40 and reduction of headache at 24 h after surgery."9.22Sumatriptan improves postoperative quality of recovery and reduces postcraniotomy headache after cranial nerve decompression. ( Bailey, T; Li, L; Manninen, PH; Tymianski, M; Venkatraghavan, L, 2016)
" We randomized patients to either naproxen 500 mg or sumatriptan 100 mg for headache recurrence after ED discharge."9.14Treating headache recurrence after emergency department discharge: a randomized controlled trial of naproxen versus sumatriptan. ( Bijur, PE; Dua, N; Esses, D; Friedman, BW; Gallagher, EJ; Heins, A; Hochberg, M; Lipton, RB; Sasso, P; Solorzano, C; Xia, S, 2010)
"To determine the efficacy of sumatriptan in the management of patients presenting for an epidural blood patch for the management of postdural puncture headache."9.09Sumatriptan in patients with postdural puncture headache. ( Connelly, NR; Gibson, CS; Parker, RK; Rahimi, A, 2000)
" Nitroglycerin (NTG) administration commonly causes a headache with some features similar to those of a migraine."9.09The pharmacodynamics of sumatriptan in nitroglycerin-induced headache. ( Forrest, A; Fullerton, T; Gengo, FM; Komorowski-Swiatek, D, 1999)
"Eight female patients (ages 34-45 years old) participated in the trial and experienced a total of 13 post-ECT headaches, which were treated with intranasal sumatriptan."9.09Intranasal sumatriptan in post-ECT headache: results of an open-label trial. ( Beale, MD; Burns, C; DeVane, CL; Folk, J; Kellner, CH; Liston, HL; Markowitz, JS, 2001)
"Sumatriptan is a selective 5-hydroxytryptamine1d (5-HT1d)-receptor agonist, highly effective in the short-term treatment of migraine headaches."9.08Cerebral and ocular hemodynamic effects of sumatriptan in the nitroglycerin headache model. ( Eichler, HG; Findl, O; Graselli, U; Krejcy, K; Schmetterer, L; Singer, EA; Wolzt, M, 1996)
"In a pilot study (5 patients) we investigated the effects of subcutaneous sumatriptan, a 5-HT1-like receptor agonist, on headache experienced during the withdrawal period of drug-induced headache."9.07Subcutaneous sumatriptan in the treatment of headache during withdrawal from drug-induced headache. ( Dichgans, J; Diener, HC; Haab, J; Peters, C; Pilgrim, A; Ried, S, 1991)
"Subcutaneous treatment of chronic tension-type headache with 2 mg and 4 mg sumatriptan, a selective 5-hydroxytryptamine1-like receptor agonist, was compared with placebo in a double-blind crossover study of 36 patients."9.07The 5-HT1-like agonist sumatriptan has a significant effect in chronic tension-type headache. ( Brennum, J; Kjeldsen, M; Olesen, J, 1992)
"For more than a century, aspirin has been used for the acute treatment of primary headaches."8.90Pharmacokinetics and safety of a new aspirin formulation for the acute treatment of primary headaches. ( D'Alonzo, L; Lecchi, M; Martelletti, P; Negro, A, 2014)
"In this study, we determine the effectiveness and adverse effects of sumatriptan when used in the emergency department (ED) as a first-line treatment for benign undifferentiated headaches, and determine if the International Headache Society (IHS) classification of migraine, probable migraine, or tension-type headache has any effect on the effectiveness of the treatment."7.74Sumatriptan for the treatment of undifferentiated primary headaches in the ED. ( Biros, M; Miner, JR; Moore, J; Smith, SW, 2007)
"To study the efficacy and practicality of treating headache in professional footballers with intranasal sumatriptan."7.73Open label study of intranasal sumatriptan (Imigran) for footballer's headache. ( Heywood, J; McCrory, P; Ugoni, A, 2005)
"To document the relationship between the 5-HT receptor agonist sumatriptan and a change in the nature of cluster headache in four cases."7.70Alteration in nature of cluster headache during subcutaneous administration of sumatriptan. ( Hering-Hanit, R, 2000)
"The use of sumatriptan for the treatment of migraine and cluster headache is well established."7.70Sumatriptan for headache caused by head and neck cancer. ( Manfredi, PL; Payne, R; Shenoy, S, 2000)
"Headache recurrence (HR) is the major limitation of sumatriptan in the acute treatment of migraine attacks."7.69Risk factors for headache recurrence after sumatriptan: a study in 366 migraine patients. ( de Vriend, RH; Ferrari, MD; Jaspers, NM; Visser, WH, 1996)
"We describe the case report of a migraine sufferer who developed ergotamine-induced headache and subsequently replaced ergotamine with daily sumatriptan (100 mg p."7.69Ergotamine-induced headache can be sustained by sumatriptan daily intake. ( Argentino, C; Catarci, T; Cerbo, R; Fiacco, F; Sette, G, 1994)
"Seven patients with posttraumatic headaches refractory to other medical treatment were treated with sumatriptan, 6 mg subcutaneously, at the peak of a headache."7.68Subcutaneous sumatriptan in the treatment of acute episodes of posttraumatic headache. ( Gawel, MJ; Jacobs, H; Rothbart, P, 1993)
"Headache is a common presenting condition for patients seen in the pediatric emergency department (ED)."7.01Sumatriptan as a First-Line Treatment for Headache in the Pediatric Emergency Department. ( Barry, D; Blume, H; Hartford, EA; Hauser Chatterjee, J; Law, E, 2023)
"Headache was rated on a 10 points scale."6.68Headache induced by a nitric oxide donor (nitroglycerin) responds to sumatriptan. A human model for development of migraine drugs. ( Iversen, HK; Olesen, J, 1996)
"Our data suggest that sumatriptan reduces central sensitization (secondary hyperalgesia) without modulating peripheral sensitization (primary hyperalgesia) in a human pain model of capsaicin-induced sensitization."5.51Sumatriptan prevents central sensitization specifically in the trigeminal dermatome in humans. ( Basedau, H; Jürgens, T; May, A; Ortlieb, L; Peng, KP, 2022)
" Compared to other active drugs, it only showed a lower significant effect compared with granisetron regarding headache change while it showed significantly higher effects only with placebo in both rescue medication needs and headache-free symptoms and valproate in only rescue medication need."5.41The efficacy and safety of metoclopramide in relieving acute migraine attacks compared with other anti-migraine drugs: a systematic review and network meta-analysis of randomized controlled trials. ( Abd-ElGawad, M; Abdelhay, HM; Abdelmonem, H; Abdelwadoud, GT; Ahmed, AE; Al-Dardery, NM; Alhosini, ANM; Kamel, MA; Mohamed, SW, 2023)
"Sumatriptan was developed as an agent for the treatment of acute migraine."5.35Subcutaneous sumatriptan relieved migraine-like headache in two adolescents with aseptic meningitis. ( Alapati, D; Khanna, S; Pallimalli, SL; Prokhorov, S, 2008)
"Post-treatment with ketorolac was more effective in attenuating PACAP38-induced headache compared to sumatriptan."5.34Investigation of sumatriptan and ketorolac trometamol in the human experimental model of headache. ( Al-Karagholi, MA; Amin, FM; Arngrim, N; Ashina, M; Ghanizada, H; Larsson, HBW; Metcalf-Clausen, M; Mørch-Rasmussen, M, 2020)
"To investigate the effect of levcromakalim on the cranial arteries and to explore the possible relationship between the middle meningeal artery (MMA) dilation and headache."5.30Levcromakalim, an Adenosine Triphosphate-Sensitive Potassium Channel Opener, Dilates Extracerebral but not Cerebral Arteries. ( Al-Karagholi, MA; Amin, FM; Ashina, M; Ghanizada, H; Hansen, JM; Larsson, HBW; Olesen, J; Skovgaard, LT, 2019)
"Cilostazol induced a mild to moderate headache in all but 3 participants (Range 0-7 on Numerical Rating Scale)."5.27Pre-treatment with sumatriptan for cilostazol induced headache in healthy volunteers. ( Falkenberg, K; Olesen, J, 2018)
"Use of sumatriptan improved the quality of recovery as measured by the QoR-40 and reduction of headache at 24 h after surgery."5.22Sumatriptan improves postoperative quality of recovery and reduces postcraniotomy headache after cranial nerve decompression. ( Bailey, T; Li, L; Manninen, PH; Tymianski, M; Venkatraghavan, L, 2016)
" At the time of discharge, for patients randomized to comprehensive care, the research team reinforced their diagnosis, shared a migraine education presentation from the National Library of Medicine, provided them with six tablets of sumatriptan 100 mg and 14 tablets of naproxen 500 mg, and if they wished, provided them with an expedited free appointment to the institution's headache clinic."5.16A randomized controlled trial of a comprehensive migraine intervention prior to discharge from an emergency department. ( Adewumni, V; Bijur, PE; Campbell, CM; Esses, D; Friedman, BW; John Gallagher, E; Lipton, RB; Norton, J; Solomon, S; Solorzano, C, 2012)
" We randomized patients to either naproxen 500 mg or sumatriptan 100 mg for headache recurrence after ED discharge."5.14Treating headache recurrence after emergency department discharge: a randomized controlled trial of naproxen versus sumatriptan. ( Bijur, PE; Dua, N; Esses, D; Friedman, BW; Gallagher, EJ; Heins, A; Hochberg, M; Lipton, RB; Sasso, P; Solorzano, C; Xia, S, 2010)
"To determine the impact of sumatriptan prophylaxis on acute mountain sickness (AMS) and altitude headache development within 24 hours of ascent, we designed a double-blind, randomized, clinical trial."5.12Sumatriptan for prevention of acute mountain sickness: randomized clinical trial. ( Gorouhi, F; Jafarian, S; Lotfi, J; Salimi, S, 2007)
"Eight female patients (ages 34-45 years old) participated in the trial and experienced a total of 13 post-ECT headaches, which were treated with intranasal sumatriptan."5.09Intranasal sumatriptan in post-ECT headache: results of an open-label trial. ( Beale, MD; Burns, C; DeVane, CL; Folk, J; Kellner, CH; Liston, HL; Markowitz, JS, 2001)
"To determine the efficacy of sumatriptan in the management of patients presenting for an epidural blood patch for the management of postdural puncture headache."5.09Sumatriptan in patients with postdural puncture headache. ( Connelly, NR; Gibson, CS; Parker, RK; Rahimi, A, 2000)
" Nitroglycerin (NTG) administration commonly causes a headache with some features similar to those of a migraine."5.09The pharmacodynamics of sumatriptan in nitroglycerin-induced headache. ( Forrest, A; Fullerton, T; Gengo, FM; Komorowski-Swiatek, D, 1999)
"Sumatriptan is a selective 5-hydroxytryptamine1d (5-HT1d)-receptor agonist, highly effective in the short-term treatment of migraine headaches."5.08Cerebral and ocular hemodynamic effects of sumatriptan in the nitroglycerin headache model. ( Eichler, HG; Findl, O; Graselli, U; Krejcy, K; Schmetterer, L; Singer, EA; Wolzt, M, 1996)
"In a pilot study (5 patients) we investigated the effects of subcutaneous sumatriptan, a 5-HT1-like receptor agonist, on headache experienced during the withdrawal period of drug-induced headache."5.07Subcutaneous sumatriptan in the treatment of headache during withdrawal from drug-induced headache. ( Dichgans, J; Diener, HC; Haab, J; Peters, C; Pilgrim, A; Ried, S, 1991)
"Subcutaneous treatment of chronic tension-type headache with 2 mg and 4 mg sumatriptan, a selective 5-hydroxytryptamine1-like receptor agonist, was compared with placebo in a double-blind crossover study of 36 patients."5.07The 5-HT1-like agonist sumatriptan has a significant effect in chronic tension-type headache. ( Brennum, J; Kjeldsen, M; Olesen, J, 1992)
" There is high confidence that adolescents receiving oral sumatriptan/naproxen and zolmitriptan nasal spray are more likely to be headache-free at 2 hours than those receiving placebo."5.01Practice guideline update summary: Acute treatment of migraine in children and adolescents: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society. ( Billinghurst, L; Gersz, EM; Gloss, D; Hershey, AD; Holler-Managan, Y; Leininger, E; Licking, N; Mack, K; Oskoui, M; Potrebic, S; Pringsheim, T; Sowell, M; Victorio, MC; Yonker, M; Zanitsch, H, 2019)
"For more than a century, aspirin has been used for the acute treatment of primary headaches."4.90Pharmacokinetics and safety of a new aspirin formulation for the acute treatment of primary headaches. ( D'Alonzo, L; Lecchi, M; Martelletti, P; Negro, A, 2014)
" Attack treatment in cluster headache is based on sumatriptan and oxygen."4.82[Treatment of cluster headache]. ( Fabre, N, 2005)
" For the acute treatment of migraine attacks or tension-type headache, ibuprofen (10 mg per kg body weight) or acetaminophen (15 mg per kg body weight) are recommended with highest evidence, intranasal sumatriptan (10 to 20 mg) can be given as second choice."4.81[Treatment of idiopathic headache in childhood - recommendations of the German Migraine and Headache Society (DMKG)]. ( Evers, S; Gerber, WD; Naumann, E; Pothmann, R; Uberall, M, 2002)
"Headache care specialists agree that the introduction of sumatriptan constitutes a major advance in headache therapy, but they differ about whether other triptans offer clinically significant advantages over sumatriptan."4.81Triptans: do they differ? ( Salonen, R; Scott, A, 2002)
" In placebo-controlled clinical trials, sumatriptan, administered subcutaneously, orally, intranasally or rectally was significantly more effective than placebo in relieving migraine headache and in producing relief or resolution of other symptoms associated with migraine, including nausea, photophobia and phonophobia."4.81Sumatriptan: pharmacological basis and clinical results. ( Dahlöf, CG, 2001)
"To assess the reimbursement options and accessibility of three effective medicines for cluster headache (CH) (subcutaneous sumatriptan, oxygen, and zolmitriptan spray) across the European Union (EU)."3.96Availability of Effective Evidence-Based Symptomatic Treatments for Cluster Headache in the EU Countries-A Survey of the European Headache Alliance and European Headache Federation. ( De La Torre, ER; Di Lorenzo, C; Mitsikostas, D; Palmaro, A; Rossi, P, 2020)
"The present study showed that repeated IS stimulations induced long-lasting allodynia, increased BBB permeability, and upregulated VEGF expression, all of which could be attenuated by early sumatriptan treatment."3.88Recurrent Headache Increases Blood-Brain Barrier Permeability and VEGF Expression in Rats. ( Chen, L; Mi, X; Qin, G; Ran, L, 2018)
"In this study, we determine the effectiveness and adverse effects of sumatriptan when used in the emergency department (ED) as a first-line treatment for benign undifferentiated headaches, and determine if the International Headache Society (IHS) classification of migraine, probable migraine, or tension-type headache has any effect on the effectiveness of the treatment."3.74Sumatriptan for the treatment of undifferentiated primary headaches in the ED. ( Biros, M; Miner, JR; Moore, J; Smith, SW, 2007)
"To study the efficacy and practicality of treating headache in professional footballers with intranasal sumatriptan."3.73Open label study of intranasal sumatriptan (Imigran) for footballer's headache. ( Heywood, J; McCrory, P; Ugoni, A, 2005)
" The objective of this investigation was to develop a disease model to predict measures of headache in randomized placebo-controlled clinical trials investigating oral sumatriptan as a paradigm compound."3.73Prediction of headache response in migraine treatment. ( Danhof, M; Della Pasqua, OE; Maas, HJ, 2006)
" Sumatriptan, an agonist of 5-HT1-like receptors, has proven effective in the treatment of cluster headache attacks."3.70Chronic paroxysmal hemicrania and hemicrania continua: lack of efficacy of sumatriptan. ( Antonaci, F; Caminero, AB; Pareja, JA; Sjaastad, O, 1998)
"The use of sumatriptan for the treatment of migraine and cluster headache is well established."3.70Sumatriptan for headache caused by head and neck cancer. ( Manfredi, PL; Payne, R; Shenoy, S, 2000)
"To document the relationship between the 5-HT receptor agonist sumatriptan and a change in the nature of cluster headache in four cases."3.70Alteration in nature of cluster headache during subcutaneous administration of sumatriptan. ( Hering-Hanit, R, 2000)
"It is concluded that MD is associated with headache that can be handicapping, and tricyclic antidepressants with pain alleviating medication is often needed to treat the headache in MD whereas sumatriptan did not alleviate the headache of the non-migraine patients."3.70Headache in Meniere's disease. ( Eklund, S, 1999)
"We describe the case report of a migraine sufferer who developed ergotamine-induced headache and subsequently replaced ergotamine with daily sumatriptan (100 mg p."3.69Ergotamine-induced headache can be sustained by sumatriptan daily intake. ( Argentino, C; Catarci, T; Cerbo, R; Fiacco, F; Sette, G, 1994)
"Headache recurrence (HR) is the major limitation of sumatriptan in the acute treatment of migraine attacks."3.69Risk factors for headache recurrence after sumatriptan: a study in 366 migraine patients. ( de Vriend, RH; Ferrari, MD; Jaspers, NM; Visser, WH, 1996)
"Seven patients with posttraumatic headaches refractory to other medical treatment were treated with sumatriptan, 6 mg subcutaneously, at the peak of a headache."3.68Subcutaneous sumatriptan in the treatment of acute episodes of posttraumatic headache. ( Gawel, MJ; Jacobs, H; Rothbart, P, 1993)
"Headache is a common presenting condition for patients seen in the pediatric emergency department (ED)."3.01Sumatriptan as a First-Line Treatment for Headache in the Pediatric Emergency Department. ( Barry, D; Blume, H; Hartford, EA; Hauser Chatterjee, J; Law, E, 2023)
"The origin of migraine pain is unknown but possibly implicates the dura mater, which is pain sensitive in proximity to the meningeal arteries."2.90Meningeal contribution to migraine pain: a magnetic resonance angiography study. ( Amin, FM; Ashina, M; Christensen, CE; de Koning, PJH; Ghanizada, H; Khan, S; Larsson, HBW; Olinger, ACR; Younis, S, 2019)
"Headache is one of the most common symptoms of COVID."2.82Post-COVID Headache: A Literature Review. ( Chhabra, N; Grill, MF; Singh, RBH, 2022)
"Sumatriptan injectable was also effective for headache relief and was found to be better than nasal spray zolmitriptan (OR 2."2.82Network meta-analysis of therapies for cluster headache: Effects of acute therapies for episodic and chronic cluster. ( Christie, S; Hutton, B; Medrea, I; Tepper, SJ; Thavorn, K, 2022)
"PACAP38-induced headache is associated with prolonged dilatation of the MMA but not of the MCA."2.77Headache and prolonged dilatation of the middle meningeal artery by PACAP38 in healthy volunteers. ( Amin, FM; Asghar, MS; Ashina, M; de Koning, PJ; Guo, S; Hansen, AE; Hougaard, A; Larsson, HB; Olesen, J; Schytz, HW; van der Geest, RJ, 2012)
"In conclusion, it is reassuring for migraineurs that it is worthwhile taking their medication in an appropriate formulation even if they have not been able to do so early in the course of the attack."2.72Subcutaneous sumatriptan provides symptomatic relief at any pain intensity or time during the migraine attack. ( Dahlöf, C; Linde, M; Mellberg, A, 2006)
"Data from migraineurs enrolled in the active arms of a randomized, double-blind, parallel group, placebo-controlled, clinical trial were analysed."2.72Does earlier headache response equate to earlier return to functioning in patients suffering from migraine? ( Mullins, CD; Pradel, FG; Subedi, P; Varghese, AA; Weis, KA, 2006)
"Frovatriptan treatment produced an adverse events profile similar to that of placebo, and in a direct comparison study was better tolerated than sumatriptan 100 mg."2.70Tolerability and safety of frovatriptan with short- and long-term use for treatment of migraine and in comparison with sumatriptan. ( Géraud, G; Keywood, C; Spierings, EL, 2002)
"Headache was rated on a 10 points scale."2.68Headache induced by a nitric oxide donor (nitroglycerin) responds to sumatriptan. A human model for development of migraine drugs. ( Iversen, HK; Olesen, J, 1996)
"Sumatriptan was generally well tolerated, the most frequently reported event being taste disturbance."2.67Intranasal sumatriptan for the acute treatment of migraine. International Intranasal Sumatriptan Study Group. ( Ashford, E; Dahlöf, C; Dawson, R; Gilhus, NE; Lüben, V; Noronha, D; Salonen, R; Warter, JM, 1994)
"Headache associated with the chronic use of medications has become a significant problem in the management of headache."2.43[Medication-overuse headache]. ( Katsarava, Z; Rabe, K, 2006)
"In the past ten years, migraine has really entered the field of science, with a number of major advances Despite theses advances, a lot has still to be done to understand what migraine really is and to improve the management of migraine sufferers."2.41[Migraine, ten years of progress]. ( Bousser, MG, 2000)
"Headache is one of the most common disorders that occurs during the early, developmental years of life."2.41Recent development in paediatric headache. ( Galli, F; Guidetti, V, 2001)
"This headache is distinguished by its response to indomethacin therapy."2.40[Chronic paroxysmal hemicrania]. ( Morales Asín, F, 1997)
"Although headache is among the most common pain complaints seen by physicians, the measurement of health-related quality of life (HRQoL) in headache patients is in its earliest stages."2.40Evolution of the measurement of quality of life in migraine. ( Solomon, GD, 1997)
"Headaches are a common entity in the ambulatory population."2.40Diagnosis, prophylaxis, and treatment of headaches in the athlete. ( Kaplan, B; Swain, RA, 1997)
"We believe that the use of these migraine models will provide even better treatment for migraine patients in the next millennium."2.40Pharmacological aspects of experimental headache models in relation to acute antimigraine therapy. ( De Vries, P; Saxena, PR; Villalón, CM, 1999)
"The original migraine therapy, ergotamine, is highly effective in its rectal suppository formulation, when used at a subnauseating dosage."2.39Headache. ( Raskin, NH, 1994)
"That the 'primary' phenomenon in migraine with aura is neuronal ('spreading depression') seems increasingly probable, but the relationship of migraine with and without aura and of both to tension headache remains uncertain."2.38Headache and migraine. ( Ziegler, DK, 1992)
"Episodic cluster headache is more responsive to acute therapy than chronic."1.62Real-life treatment of cluster headache in a tertiary headache center - results from the Danish Cluster Headache Survey. ( Barloese, M; Jensen, RH; Lund, N; Petersen, AS, 2021)
"All patients were diagnosed as migraine by headache specialists and were treated with triptans, which resulted in satisfactory pain relief."1.51Orofacial Pain and Menstrually Related Migraine. ( Hatori, K; Hsu, YC; Imamura, Y; Nishihara, C; Noma, N; Ozasa, K; Young, A, 2019)
"The acute antimigraine efficacy of these remedies is very much dependent on the formulation used where, in general, parenteral formulations are more effective in relieving the symptoms of a migraine attack."1.38Headache currents commentary. ( Peatfield, R, 2012)
"The third woman had migraine but the attacks were not associated with HS."1.38Headache in three new cases of Harlequin syndrome with accompanying pharmacological comparison with migraine. ( Goadsby, PJ; Mathias, CJ; Viana, M, 2012)
"There was no difference in the treatments used or pain relief achieved between migraine, migrainous, and tension-type headaches."1.35Pain treatment and relief among patients with primary headache subtypes in the ED. ( Miner, J; Trainor, A, 2008)
"Sumatriptan was developed as an agent for the treatment of acute migraine."1.35Subcutaneous sumatriptan relieved migraine-like headache in two adolescents with aseptic meningitis. ( Alapati, D; Khanna, S; Pallimalli, SL; Prokhorov, S, 2008)
"All were treated for that headache with Synacthen and one also received sumatriptan before her seizures."1.31Unexplained fitting in three parturients suffering from postdural puncture headache. ( Oliver, CD; White, SA, 2002)
"Dihydroergotamine mesylate was also abortive in the few instances when the headache worsened."1.30Successful treatment of headache related to intravenous immunoglobulin with antimigraine medications. ( Finkel, AG; Howard, JF; Mann, JD, 1998)
"The pathophysiologies of migraine and cluster headache have a specific modifying property on cognitive processing reflected by a loss of cognitive habituation or an increased cognitive processing time."1.30Cognitive processing in primary headache: a study on event-related potentials. ( Bauer, B; Evers, S; Grotemeyer, KH; Husstedt, IW; Suhr, B, 1997)
"9% of the patients withdrew from the study because of insufficient efficacy or adverse events."1.30Open-labeled long-term study of the efficacy, safety, and tolerability of subcutaneous sumatriptan in acute migraine treatment. ( Göbel, H; Heinze, A; Heinze-Kuhn, K; Lindner, V; Stolze, H, 1999)

Research

Studies (149)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's61 (40.94)18.2507
2000's53 (35.57)29.6817
2010's22 (14.77)24.3611
2020's13 (8.72)2.80

Authors

AuthorsStudies
Medrea, I1
Christie, S1
Tepper, SJ2
Thavorn, K1
Hutton, B1
Panda, PK1
Ramachandran, A1
Sharawat, IK1
Bhat, NK1
Peng, KP1
Jürgens, T1
Basedau, H1
Ortlieb, L1
May, A2
Chhabra, N1
Grill, MF1
Singh, RBH1
Hauser Chatterjee, J1
Hartford, EA1
Law, E1
Barry, D1
Blume, H1
Chanchlani, R1
Agrawal, A1
Janjua, D1
Hafsa, SN1
Abdelmonem, H1
Abdelhay, HM1
Abdelwadoud, GT1
Alhosini, ANM1
Ahmed, AE1
Mohamed, SW1
Al-Dardery, NM1
Abd-ElGawad, M1
Kamel, MA1
Tajti, J1
Csáti, A1
Szok, D1
Oskoui, M1
Pringsheim, T2
Holler-Managan, Y1
Potrebic, S1
Billinghurst, L1
Gloss, D1
Hershey, AD1
Licking, N1
Sowell, M1
Victorio, MC1
Gersz, EM1
Leininger, E1
Zanitsch, H1
Yonker, M1
Mack, K1
Al-Karagholi, MA2
Ghanizada, H3
Hansen, JM1
Skovgaard, LT1
Olesen, J7
Larsson, HBW3
Amin, FM4
Ashina, M5
Nishihara, C1
Hatori, K1
Hsu, YC1
Ozasa, K1
Young, A1
Imamura, Y1
Noma, N1
Arngrim, N1
Mørch-Rasmussen, M1
Metcalf-Clausen, M1
da Silva Fiorin, F1
do Espírito Santo, CC1
do Nascimento, RS1
Cassol, G1
Plácido, E1
Santos, ARS1
Marques, JLB1
Brocardo, PS1
Fighera, MR1
Royes, LFF1
Son, M1
Kim, DD1
Kiwan, R1
Mayich, M1
Khaw, AV1
Petersen, AS1
Lund, N1
Jensen, RH1
Barloese, M1
Borchard-Tuch, C1
Falkenberg, K1
Mi, X1
Ran, L1
Chen, L1
Qin, G1
Khan, S1
Christensen, CE1
Younis, S1
Olinger, ACR1
de Koning, PJH1
Rossi, P1
De La Torre, ER1
Mitsikostas, D1
Di Lorenzo, C1
Palmaro, A1
Levin, M1
Lecchi, M1
D'Alonzo, L1
Negro, A1
Martelletti, P1
Diener, HC5
Dodick, DW1
Venkatraghavan, L1
Li, L1
Bailey, T1
Manninen, PH1
Tymianski, M1
Prokhorov, S1
Khanna, S1
Alapati, D1
Pallimalli, SL1
Trainor, A1
Miner, J1
Kruuse, C1
Iversen, HK2
Jansen-Olesen, I1
Edvinsson, L1
Friedman, BW2
Solorzano, C2
Esses, D2
Xia, S1
Hochberg, M1
Dua, N1
Heins, A1
Sasso, P1
Bijur, PE2
Lipton, RB3
Gallagher, EJ1
Asghar, MS3
Hansen, AE2
Kapijimpanga, T1
van der Geest, RJ2
van der Koning, P1
Larsson, HB2
Tfelt-Hansen, PC1
Baskar, S1
Etti, R1
Kitas, G1
Klocke, R1
Guo, S1
Hougaard, A1
Schytz, HW1
de Koning, PJ1
Peatfield, R1
Viana, M1
Mathias, CJ1
Goadsby, PJ2
Hunter, BR1
Seupaul, RA1
Lee, LY1
Abbott, L1
Mahlangu, B1
Moodie, SJ1
Anderson, S1
Norton, J1
Adewumni, V1
Campbell, CM1
Solomon, S1
John Gallagher, E1
Oliver, CD1
White, SA1
Katsarava, Z3
Dahlöf, CG1
Lampl, C1
Buzath, A1
Yazdi, K1
Sandor, PS1
Utiger, D1
Eichenberger, U1
Bernasch, D1
Baumgartner, RW2
Bärtsch, P2
Goldman, MD1
Login, IS1
Iizuka, T1
Sakai, F1
Endo, M1
Suzuki, N1
Silberstein, SD2
McCarroll, KA1
Lines, CR1
D'Andrea, G1
Terrazzino, S1
Leon, A1
Fortin, D1
Perini, F1
Granella, F1
Bussone, G1
Mellick, LB1
Mellick, GA1
Drucker, P1
Tepper, S1
Rosenberg, JH1
Rothrock, J1
Kabbouche, MA1
Linder, SL1
McCrory, P1
Heywood, J1
Ugoni, A1
Fabre, N1
Linde, M1
Mellberg, A1
Dahlöf, C3
Maas, HJ1
Danhof, M1
Della Pasqua, OE1
Pradel, FG1
Subedi, P1
Varghese, AA1
Mullins, CD1
Weis, KA1
White, PF1
Purdue, L1
Downing, M1
Thornton, L1
Rabe, K1
Prasad, S1
El-Haddad, G1
Zhuang, H1
Khella, S1
Miner, JR1
Smith, SW1
Moore, J1
Biros, M1
Ducros, A1
Jafarian, S1
Gorouhi, F1
Salimi, S1
Lotfi, J1
Alstadhaug, K1
Breivik, K1
Rusic, Z1
Jürgens, TP1
Busch, V1
Schmidt-Wilcke, T1
Schuierer, G1
Leinisch, E1
Pope, JV1
Edlow, JA1
Rohmer, C1
Le Bourlot, G1
Stallard, N1
Barry, P1
Stewart, WF1
Ghose, RR1
Burtscher, M1
Likar, R1
Nachbauer, W1
Schaffert, W1
Philadelphy, M1
Catarci, T2
Lenzi, GL1
Cerbo, R2
Fieschi, C1
Koehler, PJ1
Mulder, LJ1
Fiacco, F1
Argentino, C1
Sette, G1
Salonen, R2
Ashford, E1
Dawson, R1
Gilhus, NE1
Lüben, V1
Noronha, D1
Warter, JM1
Maggi, S1
Kleger, GR1
Ballmer, PE1
Raskin, NH2
Carp, H1
Singh, PJ1
Vadhera, R1
Jayaram, A1
Araki, S1
Caekebeke, JF1
Ferrari, MD2
Gawel, MJ1
Rothbart, P1
Jacobs, H1
Mathew, NT1
Ravishankar, K1
Sanin, LC1
Göbel, H2
Stolze, H2
Heinze, A2
Dworschak, M1
Freiherr Von Hornstein, W1
Reich, A1
Bonuccelli, U1
Nuti, A1
Lucetti, C1
Pavese, N1
Dell'Agnello, G1
Muratorio, A1
Verheggen, R1
Freudenthaler, S1
Meyer-Dulheuer, F1
Kaumann, AJ1
Pfaffenrath, V1
Visser, WH1
Jaspers, NM1
de Vriend, RH1
Schmetterer, L1
Wolzt, M1
Krejcy, K1
Graselli, U1
Findl, O1
Eichler, HG1
Singer, EA1
Van Gelderen, EM1
Saxena, PR2
Furlong, S1
Pryse-Phillips, W1
Crowley, M1
Turner, CJ1
Lhuissier, C1
Mercier, FJ1
Dounas, M1
Benhamou, D1
Evers, S2
Bauer, B1
Suhr, B1
Husstedt, IW1
Grotemeyer, KH1
Solomon, GD1
Hodgson, C1
Roitberg-Henry, A1
Swain, RA1
Kaplan, B1
Hutter, CD1
de las Heras-Rosas, MA1
Rodríguez-Pérez, A1
Ojeda-Betancor, N1
Boralla-Rivera, G1
Gallego-Alonso, JI1
Morales Asín, F1
Antonaci, F1
Pareja, JA1
Caminero, AB1
Sjaastad, O1
Gaist, D1
Tsiropoulos, I1
Sindrup, SH1
Hallas, J1
Rasmussen, BK1
Kragstrup, J1
Gram, LF1
Finkel, AG1
Howard, JF1
Mann, JD1
Sharfman, M1
Oms, A1
Miro, E1
Rojo, JE1
Fantz, RM1
Markowitz, JS2
Kellner, CH2
van der Kuy, PH1
Lohman, JJ1
Meijler, W1
Bell, KR1
Kraus, EE1
Zasler, ND1
Zed, PJ1
Loewen, PS1
Robinson, G1
Fullerton, T1
Komorowski-Swiatek, D1
Forrest, A1
Gengo, FM1
Sprigge, JS1
Dowson, A1
De Vries, P1
Villalón, CM1
Heinze-Kuhn, K1
Lindner, V1
Eklund, S1
Hering-Hanit, R1
Connelly, NR1
Parker, RK1
Rahimi, A1
Gibson, CS1
Pascual, J1
Morán, JC1
Sánchez, E1
Ulla, M1
del Villar, V1
Levo, H1
Blomstedt, G1
Pyykkö, I1
Roberts, RG1
Tfelt-Hansen, P1
Manfredi, PL1
Shenoy, S1
Payne, R1
Bousser, MG1
Shah, AK1
Freij, W1
Guidetti, V1
Galli, F1
Rapoport, AM1
Fritsche, G1
Muessig, M1
Limmroth, V1
DeVane, CL1
Beale, MD1
Folk, J1
Burns, C1
Liston, HL1
Pothmann, R1
Uberall, M1
Naumann, E1
Gerber, WD1
Scott, A1
Gawel, M1
Krimsky, W1
Weiss, H1
Géraud, G1
Spierings, EL1
Keywood, C1
Calero Muñoz, S1
Fariñas Balaguer, O1
Nieto Márquez, L1
Cobo Guerrero, S1
van der Post, J1
Schram, MT1
Schoemaker, RC1
Pieters, MS1
Fuseau, E1
Pereira, A1
Baggen, S1
Cohen, AF1
van Gerven, JM1
Ziegler, DK1
Wilkinson, M1
Hsu, VD1
Brennum, J1
Kjeldsen, M1
Haab, J1
Peters, C1
Ried, S1
Dichgans, J1
Pilgrim, A1

Clinical Trials (7)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
The Effect of Levcromakalim Infusion on the Cranial Arteries Over Several Hours Using a High Resolution MRA Technique in a Randomized, Double-blind Placebo-controlled Design in Healthy Volunteers.[NCT03609008]20 participants (Actual)Interventional2018-06-26Completed
The Role of Inflammation and Vasodilatation in PACAP38-induced Headache Using MRI on Healthy Subjects[NCT03585894]34 participants (Actual)Interventional2018-08-01Completed
Pretreatment With Sumatriptan on Cilostazol Induced Headache in Healthy Volunteers. Development of a Pragmatic Migraine Model[NCT03156920]30 participants (Actual)Interventional2017-05-23Completed
Effect of Sumatriptan on the Postoperative Quality of Recovery After Elective Minimally Invasive Craniotomy[NCT01632657]40 participants (Actual)Interventional2012-06-30Completed
Understanding the Role of the External Carotid Artery in the Pathophysiology of Migraine Pain[NCT03026101]20 participants (Anticipated)Interventional2017-01-31Enrolling by invitation
A Preliminary Investigation of the Efficacy of Aromatherapy in Reducing Discomfort in Youth With Chronic Headache[NCT02440997]46 participants (Actual)Interventional2015-03-25Completed
The Check Trial: A Comparison of Headache Treatment in the ED: Compazine Versus Ketamine. A Multi-Center, Randomized Double-Blind, Clinical Control Trial.[NCT02657031]Phase 454 participants (Actual)Interventional2016-03-17Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Anxiety

Reduction in 100 mm Visual Analog Scale (VAS) Score. The maximum possible change in VAS score is 100 mm, representing the complete relief of maximum anxiety. A change of 0 mm corresponds to no change in anxiety level, and a negative value indicates worsening of the anxiety after the medication. (NCT02657031)
Timeframe: 0-60 minutes

Interventionmm (Mean)
Control Arm33.7
Study Arm21.2

Headache Following Intervention

Reduction in 100 mm Visual Analog Scale (VAS) Score. Positive values represent a reduction in headache severity. The maximum possible change in VAS score is 100 mm, representing the complete relief of a maximally severe headache. A change of 0 mm corresponds to no change in headache severity, and a negative value indicates worsening of the headache after the medication. (NCT02657031)
Timeframe: 0-60 minutes

Interventionmm (Mean)
Control Arm63.5
Study Arm43.5

Nausea

Reduction in 100 mm Visual Analog Scale (VAS) Score. The maximum possible change in VAS score is 100 mm, representing the complete relief of maximum nausea. A change of 0 mm corresponds to no change in nausea level, and a negative value indicates worsening of the nausea after the medication. (NCT02657031)
Timeframe: 0-60 minutes

Interventionmm (Mean)
Control Arm38.9
Study Arm22.9

The Number of Participants Experiencing Vomiting

Yes/No (NCT02657031)
Timeframe: 0-60 minutes

Interventionparticipants (Number)
Control Arm2
Study Arm3

The Number of Patients Experiencing Restlessness

Yes/No (NCT02657031)
Timeframe: 0-60 minutes

Interventionparticipants (Number)
Control Arm3
Study Arm3

Reviews

38 reviews available for sumatriptan and Headache

ArticleYear
Network meta-analysis of therapies for cluster headache: Effects of acute therapies for episodic and chronic cluster.
    Headache, 2022, Volume: 62, Issue:4

    Topics: Adolescent; Adult; Bayes Theorem; Cluster Headache; Headache; Humans; Nasal Sprays; Network Meta-Ana

2022
Post-COVID Headache: A Literature Review.
    Current pain and headache reports, 2022, Volume: 26, Issue:11

    Topics: COVID-19; Epilepsy; Female; Headache; Humans; Migraine Disorders; Sumatriptan

2022
Sumatriptan as a First-Line Treatment for Headache in the Pediatric Emergency Department.
    Pediatric neurology, 2023, Volume: 142

    Topics: Child; Emergency Service, Hospital; Female; Headache; Humans; Male; Migraine Disorders; Retrospectiv

2023
The Efficacy of Different Triptans for the Treatment of Acute Headache in Pediatric Migraine: A Systematic Review.
    Indian pediatrics, 2023, 08-15, Volume: 60, Issue:8

    Topics: Adolescent; Child; Headache; Humans; Migraine Disorders; Naproxen; Sumatriptan; Tryptamines

2023
The efficacy and safety of metoclopramide in relieving acute migraine attacks compared with other anti-migraine drugs: a systematic review and network meta-analysis of randomized controlled trials.
    BMC neurology, 2023, Jun-08, Volume: 23, Issue:1

    Topics: Chlorpromazine; Granisetron; Headache; Humans; Ketorolac; Metoclopramide; Migraine Disorders; Nausea

2023
[Sumatriptan-naproxen sodium fix-dose combination for acute migraine treatment, a review].
    Ideggyogyaszati szemle, 2023, Sep-30, Volume: 76, Issue:9-10

    Topics: Double-Blind Method; Drug Therapy, Combination; Headache; Humans; Migraine Disorders; Naproxen; Qual

2023
Practice guideline update summary: Acute treatment of migraine in children and adolescents: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society.
    Neurology, 2019, 09-10, Volume: 93, Issue:11

    Topics: Academies and Institutes; Adolescent; Child; Drug Combinations; Headache; Humans; Migraine Disorders

2019
Pharmacokinetics and safety of a new aspirin formulation for the acute treatment of primary headaches.
    Expert opinion on drug metabolism & toxicology, 2014, Volume: 10, Issue:10

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dose-Response Relationship, Drug; Headache; Humans

2014
Headache research in 2015: progress in migraine treatment.
    The Lancet. Neurology, 2016, Volume: 15, Issue:1

    Topics: Analgesics; Antibodies, Monoclonal; Biomedical Research; Headache; Humans; Migraine Disorders; Sumat

2016
Are there pharmacologic agents that safely and effectively treat post-lumbar puncture headache?
    Annals of emergency medicine, 2013, Volume: 61, Issue:1

    Topics: Adrenocorticotropic Hormone; Caffeine; Central Nervous System Stimulants; Headache; Humans; Injectio

2013
The management of cyclic vomiting syndrome: a systematic review.
    European journal of gastroenterology & hepatology, 2012, Volume: 24, Issue:9

    Topics: Adrenergic beta-Antagonists; Age of Onset; Antidepressive Agents, Tricyclic; Depression; Female; Hea

2012
Effects of glyceryl trinitrate and calcitonin gene-related peptide on BOLD signal and arterial diameter: methodological studies by fMRI and MRA.
    Danish medical journal, 2012, Volume: 59, Issue:7

    Topics: Acetazolamide; Adolescent; Adult; Anticonvulsants; Brain; Calcitonin Gene-Related Peptide; Cerebral

2012
Medication overuse headache.
    Current medical research and opinion, 2001, Volume: 17 Suppl 1

    Topics: Analgesics; Ergot Alkaloids; Headache; Humans; Migraine Disorders; Narcotics; Serotonin Receptor Ago

2001
Sumatriptan: pharmacological basis and clinical results.
    Current medical research and opinion, 2001, Volume: 17 Suppl 1

    Topics: Administration, Inhalation; Headache; Humans; Injections; Migraine Disorders; Patient Satisfaction;

2001
Acute treatment of pediatric headache in the emergency department and inpatient settings.
    Pediatric annals, 2005, Volume: 34, Issue:6

    Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Child; Dihydroergotamine; D

2005
[Treatment of cluster headache].
    Revue neurologique, 2005, Volume: 161, Issue:6-7

    Topics: Cluster Headache; Facial Pain; Headache; Humans; Oxygen Inhalation Therapy; Sumatriptan; Trigeminal

2005
[Medication-overuse headache].
    MMW Fortschritte der Medizin, 2006, Aug-31, Volume: 148, Issue:35-36

    Topics: Acute Disease; Analgesics; Analgesics, Non-Narcotic; Chronic Disease; Ergotamine; Female; Headache;

2006
[Acute and chronic headaches].
    La Revue du praticien, 2006, Dec-15, Volume: 56, Issue:19

    Topics: Acetaminophen; Adult; Aged; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Aspir

2006
Favorable response to analgesics does not predict a benign etiology of headache.
    Headache, 2008, Volume: 48, Issue:6

    Topics: Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Antiemetics; Headache; Humans; Serotonin Recept

2008
Headache.
    The Western journal of medicine, 1994, Volume: 161, Issue:3

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Ergotamine; Headache; Humans; Migraine Disorders; Sumatript

1994
[Diagnosis and therapy of headaches].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1993, Mar-10, Volume: 82, Issue:3

    Topics: Adrenergic beta-Antagonists; Ergotamine; Headache; Humans; Indoles; Serotonin Receptor Agonists; Sul

1993
Evolution of the measurement of quality of life in migraine.
    Neurology, 1997, Volume: 48, Issue:3 Suppl 3

    Topics: Attitude to Health; Emotions; Headache; Health Status; Humans; Mental Health; Migraine Disorders; Pa

1997
Diagnosis, prophylaxis, and treatment of headaches in the athlete.
    Southern medical journal, 1997, Volume: 90, Issue:9

    Topics: Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents, Tricyclic;

1997
[Chronic paroxysmal hemicrania].
    Neurologia (Barcelona, Spain), 1997, Volume: 12 Suppl 5

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Diagnosis, Differential; Female; He

1997
Update on headache.
    Comprehensive therapy, 1998, Volume: 24, Issue:4

    Topics: Analgesics, Non-Narcotic; Ergotamine; Headache; Humans; Patient Selection; Sumatriptan; Vasoconstric

1998
Medical management of posttraumatic headaches: pharmacological and physical treatment.
    The Journal of head trauma rehabilitation, 1999, Volume: 14, Issue:1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Craniocerebral Trauma; Ergotamine; Headach

1999
Medication-induced headache: overview and systematic review of therapeutic approaches.
    The Annals of pharmacotherapy, 1999, Volume: 33, Issue:1

    Topics: Amitriptyline; Analgesics; Anti-Inflammatory Agents; Chronic Disease; Ergolines; Headache; Humans; M

1999
Pharmacological aspects of experimental headache models in relation to acute antimigraine therapy.
    European journal of pharmacology, 1999, Jun-30, Volume: 375, Issue:1-3

    Topics: Animals; Disease Models, Animal; Forecasting; Headache; Humans; Migraine Disorders; Models, Biologic

1999
[Migraine, ten years of progress].
    Annales pharmaceutiques francaises, 2000, Volume: 58, Issue:6

    Topics: Brain; Headache; Humans; Migraine Disorders; Serotonin Receptor Agonists; Sumatriptan

2000
Recent development in paediatric headache.
    Current opinion in neurology, 2001, Volume: 14, Issue:3

    Topics: Adolescent; Analgesics; Child; Clinical Trials as Topic; Diagnosis, Differential; Headache; Humans;

2001
Triptans are all different.
    Archives of neurology, 2001, Volume: 58, Issue:9

    Topics: Carbazoles; Headache; Humans; Indoles; Oxazolidinones; Pyrrolidines; Serotonin Receptor Agonists; Su

2001
[Treatment of idiopathic headache in childhood - recommendations of the German Migraine and Headache Society (DMKG)].
    Schmerz (Berlin, Germany), 2002, Volume: 16, Issue:1

    Topics: Acetaminophen; Adrenergic beta-Antagonists; Age Factors; Analgesics, Non-Narcotic; Biofeedback, Psyc

2002
Triptans: do they differ?
    Current pain and headache reports, 2002, Volume: 6, Issue:2

    Topics: Clinical Trials as Topic; Dosage Forms; Headache; Humans; Serotonin Receptor Agonists; Sumatriptan

2002
Triptans: are they all the same?
    Current pain and headache reports, 2002, Volume: 6, Issue:2

    Topics: Drug Interactions; Headache; Humans; Receptors, Serotonin; Serotonin Receptor Agonists; Sumatriptan

2002
Cryptic pituitary hemorrhage presenting with headache.
    Headache, 2002, Volume: 42, Issue:4

    Topics: Adenoma; Cysts; Headache; Hemorrhage; Humans; Male; Middle Aged; Pituitary Neoplasms; Sumatriptan

2002
[The latest in headache treatment].
    Atencion primaria, 2002, May-31, Volume: 29, Issue:9

    Topics: Acetaminophen; Adolescent; Adult; Aged; Analgesics; Analgesics, Non-Narcotic; Angiotensin-Converting

2002
Headache and migraine.
    Current opinion in neurology and neurosurgery, 1992, Volume: 5, Issue:2

    Topics: Arousal; Brain; Electroencephalography; Headache; Humans; Indoles; Migraine Disorders; Regional Bloo

1992
Management of headache.
    The Practitioner, 1992, Volume: 236, Issue:1513

    Topics: Diagnosis, Differential; Headache; Humans; Indoles; Migraine Disorders; Sulfonamides; Sumatriptan; V

1992

Trials

27 trials available for sumatriptan and Headache

ArticleYear
Sumatriptan prevents central sensitization specifically in the trigeminal dermatome in humans.
    European journal of pain (London, England), 2022, Volume: 26, Issue:10

    Topics: Capsaicin; Central Nervous System Sensitization; Headache; Humans; Hyperalgesia; Migraine Disorders;

2022
Levcromakalim, an Adenosine Triphosphate-Sensitive Potassium Channel Opener, Dilates Extracerebral but not Cerebral Arteries.
    Headache, 2019, Volume: 59, Issue:9

    Topics: Adult; Cromakalim; Double-Blind Method; Female; Headache; Humans; Ion Channel Gating; Male; Meningea

2019
Investigation of sumatriptan and ketorolac trometamol in the human experimental model of headache.
    The journal of headache and pain, 2020, Feb-24, Volume: 21, Issue:1

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Cross-Over Studies; Double-Blind Method; Female; Hea

2020
Pre-treatment with sumatriptan for cilostazol induced headache in healthy volunteers.
    The journal of headache and pain, 2018, Aug-17, Volume: 19, Issue:1

    Topics: Adult; Cilostazol; Cross-Over Studies; Double-Blind Method; Female; Headache; Healthy Volunteers; Hu

2018
Meningeal contribution to migraine pain: a magnetic resonance angiography study.
    Brain : a journal of neurology, 2019, 01-01, Volume: 142, Issue:1

    Topics: Adolescent; Adult; Carotid Arteries; Cilostazol; Female; Headache; Humans; Magnetic Resonance Angiog

2019
Sumatriptan improves postoperative quality of recovery and reduces postcraniotomy headache after cranial nerve decompression.
    British journal of anaesthesia, 2016, Volume: 117, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cranial Nerve Diseases; Cranial Nerves; Double-Blind Met

2016
Calcitonin gene-related peptide (CGRP) levels during glyceryl trinitrate (GTN)-induced headache in healthy volunteers.
    Cephalalgia : an international journal of headache, 2010, Volume: 30, Issue:4

    Topics: Adult; Calcitonin Gene-Related Peptide; Cross-Over Studies; Female; Headache; Humans; Male; Neuropep

2010
Treating headache recurrence after emergency department discharge: a randomized controlled trial of naproxen versus sumatriptan.
    Annals of emergency medicine, 2010, Volume: 56, Issue:1

    Topics: Adult; Analgesics; Double-Blind Method; Emergency Service, Hospital; Female; Headache; Humans; Male;

2010
Dilation by CGRP of middle meningeal artery and reversal by sumatriptan in normal volunteers.
    Neurology, 2010, Oct-26, Volume: 75, Issue:17

    Topics: Adult; Area Under Curve; Blood Pressure; Calcitonin Gene-Related Peptide; Confidence Intervals; Doub

2010
Headache and prolonged dilatation of the middle meningeal artery by PACAP38 in healthy volunteers.
    Cephalalgia : an international journal of headache, 2012, Volume: 32, Issue:2

    Topics: Adult; Blood Pressure; Carbon Dioxide; Female; Headache; Heart Rate; Humans; Magnetic Resonance Angi

2012
A randomized controlled trial of a comprehensive migraine intervention prior to discharge from an emergency department.
    Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 2012, Volume: 19, Issue:10

    Topics: Adult; Emergency Service, Hospital; Female; Headache; Humans; Male; Middle Aged; Migraine Disorders;

2012
Transient minor improvement of high altitude headache by sumatriptan.
    High altitude medicine & biology, 2002,Winter, Volume: 3, Issue:4

    Topics: Adult; Altitude Sickness; Chi-Square Distribution; Double-Blind Method; Female; Headache; Humans; Ma

2002
Subcutaneous sumatriptan provides symptomatic relief at any pain intensity or time during the migraine attack.
    Cephalalgia : an international journal of headache, 2006, Volume: 26, Issue:2

    Topics: Adult; Cross-Over Studies; Female; Headache; Humans; Injections, Subcutaneous; Male; Middle Aged; Mi

2006
Does earlier headache response equate to earlier return to functioning in patients suffering from migraine?
    Cephalalgia : an international journal of headache, 2006, Volume: 26, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Comorbidity; Double-Blind Method; Female; Headache; Huma

2006
Sumatriptan for prevention of acute mountain sickness: randomized clinical trial.
    Annals of neurology, 2007, Volume: 62, Issue:3

    Topics: Acute Disease; Adolescent; Adult; Altitude Sickness; Double-Blind Method; Drug Eruptions; Endpoint D

2007
Ibuprofen versus sumatriptan for high-altitude headache.
    Lancet (London, England), 1995, Jul-22, Volume: 346, Issue:8969

    Topics: Administration, Oral; Adult; Altitude Sickness; Cross-Over Studies; Double-Blind Method; Female; Hea

1995
Intranasal sumatriptan for the acute treatment of migraine. International Intranasal Sumatriptan Study Group.
    Journal of neurology, 1994, Volume: 241, Issue:8

    Topics: Acute Disease; Administration, Intranasal; Adult; Double-Blind Method; Drug Tolerance; Female; Heada

1994
Cerebral and ocular hemodynamic effects of sumatriptan in the nitroglycerin headache model.
    Clinical pharmacology and therapeutics, 1996, Volume: 60, Issue:2

    Topics: Adult; Analysis of Variance; Blood Flow Velocity; Cerebrovascular Circulation; Double-Blind Method;

1996
Headache induced by a nitric oxide donor (nitroglycerin) responds to sumatriptan. A human model for development of migraine drugs.
    Cephalalgia : an international journal of headache, 1996, Volume: 16, Issue:6

    Topics: Adult; Blood Flow Velocity; Brain; Cross-Over Studies; Double-Blind Method; Female; Headache; Humans

1996
The pharmacodynamics of sumatriptan in nitroglycerin-induced headache.
    Journal of clinical pharmacology, 1999, Volume: 39, Issue:1

    Topics: Adult; Analysis of Variance; Area Under Curve; Brain; Cerebral Arteries; Electrocardiography; Headac

1999
Sumatriptan in patients with postdural puncture headache.
    Headache, 2000, Volume: 40, Issue:4

    Topics: Adult; Anesthesia, Epidural; Blood Patch, Epidural; Female; Headache; Humans; Injections, Subcutaneo

2000
Clinical features of withdrawal headache following overuse of triptans and other headache drugs.
    Neurology, 2001, Nov-13, Volume: 57, Issue:9

    Topics: Adult; Analgesics; Drug Therapy, Combination; Ergotamine; Female; Headache; Humans; Indoles; Male; M

2001
Intranasal sumatriptan in post-ECT headache: results of an open-label trial.
    The journal of ECT, 2001, Volume: 17, Issue:4

    Topics: Administration, Intranasal; Adolescent; Adult; Electroconvulsive Therapy; Female; Headache; Humans;

2001
Tolerability and safety of frovatriptan with short- and long-term use for treatment of migraine and in comparison with sumatriptan.
    Headache, 2002, Volume: 42 Suppl 2

    Topics: Acute Disease; Adult; Carbazoles; Clinical Trials as Topic; Dizziness; Dose-Response Relationship, D

2002
CNS effects of sumatriptan and rizatriptan in healthy female volunteers.
    Cephalalgia : an international journal of headache, 2002, Volume: 22, Issue:4

    Topics: Adult; Affect; Brain; Cognition; Cross-Over Studies; Dizziness; Double-Blind Method; Electroencephal

2002
The 5-HT1-like agonist sumatriptan has a significant effect in chronic tension-type headache.
    Cephalalgia : an international journal of headache, 1992, Volume: 12, Issue:6

    Topics: Adult; Aged; Chronic Disease; Double-Blind Method; Female; Headache; Hemodynamics; Humans; Indoles;

1992
Subcutaneous sumatriptan in the treatment of headache during withdrawal from drug-induced headache.
    Headache, 1991, Volume: 31, Issue:4

    Topics: Adult; Cerebral Arteries; Cerebrovascular Circulation; Double-Blind Method; Ergotamine; Female; Head

1991

Other Studies

84 other studies available for sumatriptan and Headache

ArticleYear
Feasibility, Utility, and Interrater Reliability of the Cluster Headache Severity Scale, Cluster Headache Quality of Life, Cluster Headache Index, and 6-Item Headache Impact Test in Pediatric Cluster Headache.
    Journal of child neurology, 2022, Volume: 37, Issue:10-11

    Topics: Child; Cluster Headache; Feasibility Studies; Female; Headache; Humans; Male; Nasal Sprays; Predniso

2022
Orofacial Pain and Menstrually Related Migraine.
    Acta neurologica Taiwanica, 2019, Dec-15, Volume: 28(4)

    Topics: Adult; Facial Pain; Female; Headache; Humans; Middle Aged; Migraine Disorders; Sumatriptan

2019
Capsaicin-sensitive fibers mediate periorbital allodynia and activation of inflammatory cells after traumatic brain injury in rats: Involvement of TRPV1 channels in post-traumatic headache.
    Neuropharmacology, 2020, 10-01, Volume: 176

    Topics: Animals; Animals, Newborn; Capsaicin; Headache; Inflammation Mediators; Male; Nerve Fibers; Post-Tra

2020
Pearls & Oy-sters: A Journey Through Reversible Cerebral Vasoconstriction Syndrome: Sex, Drugs, and Headaches.
    Neurology, 2021, 03-30, Volume: 96, Issue:13

    Topics: Adult; Angiography, Digital Subtraction; Cerebral Hemorrhage; Cerebrovascular Disorders; Coitus; Con

2021
Real-life treatment of cluster headache in a tertiary headache center - results from the Danish Cluster Headache Survey.
    Cephalalgia : an international journal of headache, 2021, Volume: 41, Issue:5

    Topics: Cluster Headache; Cross-Sectional Studies; Denmark; Headache; Humans; Oxygen; Sumatriptan; Surveys a

2021
[In process].
    Medizinische Monatsschrift fur Pharmazeuten, 2016, Volume: 39, Issue:9

    Topics: Adolescent; Adrenergic beta-Antagonists; Age Factors; Analgesics; Behavior Therapy; Child; Flunarizi

2016
Recurrent Headache Increases Blood-Brain Barrier Permeability and VEGF Expression in Rats.
    Pain physician, 2018, Volume: 21, Issue:6

    Topics: Animals; Blood-Brain Barrier; Capillary Permeability; Headache; Hyperalgesia; Inflammation; Male; Mi

2018
Availability of Effective Evidence-Based Symptomatic Treatments for Cluster Headache in the EU Countries-A Survey of the European Headache Alliance and European Headache Federation.
    Journal of oral & facial pain and headache, 2020,Winter, Volume: 34, Issue:1

    Topics: Cluster Headache; European Union; Headache; Humans; Sumatriptan; Surveys and Questionnaires

2020
Teaching case: hypertensiveheadache.
    Headache, 2013, Volume: 53, Issue:4

    Topics: Brain Diseases; Cerebral Hemorrhage; Female; Headache; Humans; Hypertension; Middle Aged; Seizures;

2013
Subcutaneous sumatriptan relieved migraine-like headache in two adolescents with aseptic meningitis.
    Headache, 2008, Volume: 48, Issue:8

    Topics: Adolescent; Female; Headache; Humans; Injections, Subcutaneous; Male; Meningitis, Aseptic; Serotonin

2008
Pain treatment and relief among patients with primary headache subtypes in the ED.
    The American journal of emergency medicine, 2008, Volume: 26, Issue:9

    Topics: Adolescent; Adult; Aged; Droperidol; Emergency Service, Hospital; Headache; Humans; Middle Aged; Pai

2008
Intravenous aspirin (lysine acetylsalicylate) in the inpatient management of headache.
    Neurology, 2011, Apr-05, Volume: 76, Issue:14

    Topics: Aspirin; Disease Management; Headache; Humans; Infusions, Intravenous; Randomized Controlled Trials

2011
Cluster headache or giant cell arteritis?
    BMJ case reports, 2008, Volume: 2008

    Topics: Aged; Anti-Inflammatory Agents; Cluster Headache; Diagnosis, Differential; Female; Giant Cell Arteri

2008
Headache currents commentary.
    Headache, 2012, Volume: 52, Issue:4

    Topics: Analgesics; Animals; Dihydroergotamine; Ergotamine; Headache; Humans; Methysergide; Migraine Disorde

2012
Headache in three new cases of Harlequin syndrome with accompanying pharmacological comparison with migraine.
    Journal of neurology, neurosurgery, and psychiatry, 2012, Volume: 83, Issue:6

    Topics: Adult; Aged; Autonomic Nervous System Diseases; Diagnosis, Differential; Dihydroergotamine; Ergotami

2012
Unexplained fitting in three parturients suffering from postdural puncture headache.
    British journal of anaesthesia, 2002, Volume: 89, Issue:5

    Topics: Adult; Analgesia, Epidural; Anesthesia, Obstetrical; Cosyntropin; Female; Headache; Humans; Seizures

2002
Ergot and triptan overuse in Austria--an evaluation of clinical data and cost.
    Cephalalgia : an international journal of headache, 2002, Volume: 22, Issue:10

    Topics: Adult; Aged; Austria; Ergot Alkaloids; Female; Headache; Humans; Male; Middle Aged; Oxazolidinones;

2002
Misdiagnosis of migraine.
    Headache, 2003, Volume: 43, Issue:1

    Topics: Adult; Diagnostic Errors; Headache; Humans; Male; Migraine Disorders; Practice Guidelines as Topic;

2003
Response to sumatriptan in headache of MELAS syndrome.
    Neurology, 2003, Aug-26, Volume: 61, Issue:4

    Topics: Adult; Drug Evaluation; Female; Headache; Humans; Hyperemia; MELAS Syndrome; Parietal Lobe; Phenotyp

2003
[Headache in children].
    Duodecim; laaketieteellinen aikakauskirja, 2003, Volume: 119, Issue:16

    Topics: Adrenergic beta-Antagonists; Analgesics, Non-Narcotic; Antiemetics; Child; Headache; Humans; Propran

2003
[Improved pharmacokinetics. Fast tryptan with sustained response].
    MMW Fortschritte der Medizin, 2003, May-26, Volume: 145 Suppl 2

    Topics: Administration, Oral; Controlled Clinical Trials as Topic; Delayed-Action Preparations; Female; Head

2003
CNS effects of sumatriptan and rizatriptan.
    Cephalalgia : an international journal of headache, 2004, Volume: 24, Issue:1

    Topics: Adult; Affect; Brain; Cognition; Cross-Over Studies; Dizziness; Double-Blind Method; Electroencephal

2004
Headaches that could spell trouble.
    Consumer reports, 2004, Volume: 69, Issue:6

    Topics: Dihydroergotamine; Headache; Humans; Migraine Disorders; Sumatriptan

2004
Elevated levels of circulating trace amines in primary headaches.
    Neurology, 2004, May-25, Volume: 62, Issue:10

    Topics: Adolescent; Adult; Chromatography, High Pressure Liquid; Cluster Headache; Diet; Female; Headache; H

2004
Treatment of primary headache in the emergency department.
    Headache, 2004, Volume: 44, Issue:8

    Topics: Anesthetics, Local; Bupivacaine; Emergency Service, Hospital; Headache; Humans; Injections, Intramus

2004
Daily sumatriptan for detoxification from rebound.
    Headache, 1998, Volume: 38, Issue:9

    Topics: Administration, Oral; Headache; Humans; Inactivation, Metabolic; Migraine Disorders; Sumatriptan

1998
The headache of SAH responds to sumatriptan.
    Headache, 2005, Volume: 45, Issue:5

    Topics: Fatal Outcome; Female; Headache; Humans; Middle Aged; Serotonin Antagonists; Subarachnoid Hemorrhage

2005
The perils of misinterpreting a treatment response.
    Headache, 2005, Volume: 45, Issue:5

    Topics: Diagnostic Errors; Fatal Outcome; Female; Headache; Humans; Middle Aged; Serotonin Receptor Agonists

2005
Open label study of intranasal sumatriptan (Imigran) for footballer's headache.
    British journal of sports medicine, 2005, Volume: 39, Issue:8

    Topics: Administration, Intranasal; Headache; Humans; Migraine Disorders; Migraine without Aura; Pain Measur

2005
Prediction of headache response in migraine treatment.
    Cephalalgia : an international journal of headache, 2006, Volume: 26, Issue:4

    Topics: Comorbidity; Computer Simulation; Decision Support Systems, Clinical; Dose-Response Relationship, Dr

2006
Intranasal sumatriptan for prevention of post-ECT headaches.
    Headache, 2006, Volume: 46, Issue:4

    Topics: Administration, Intranasal; Electroconvulsive Therapy; Headache; Humans; Serotonin Receptor Agonists

2006
Intracranial hypotension following chiropractic spinal manipulation.
    Headache, 2006, Volume: 46, Issue:9

    Topics: Adult; Headache; Humans; Male; Serotonin Receptor Agonists; Sumatriptan

2006
Sumatriptan for the treatment of undifferentiated primary headaches in the ED.
    The American journal of emergency medicine, 2007, Volume: 25, Issue:1

    Topics: Adult; Emergency Service, Hospital; Female; Headache; Humans; Male; Migraine Disorders; Minnesota; P

2007
Recurrent headache due to MS plaque.
    Headache, 2008, Volume: 48, Issue:3

    Topics: Analgesics, Opioid; Anti-Inflammatory Agents; Female; Headache; Humans; Immunoglobulins, Intravenous

2008
Migraine-like headache in intracranial haemorrhage is alleviated by sumatriptan and almotriptan.
    Cephalalgia : an international journal of headache, 2008, Volume: 28, Issue:3

    Topics: Adult; Diagnosis, Differential; Drug Therapy, Combination; Headache; Humans; Intracranial Hemorrhage

2008
[Headache after spinal anesthesia treated with sumatriptan].
    Annales francaises d'anesthesie et de reanimation, 1995, Volume: 14, Issue:2

    Topics: Adult; Analgesics; Anesthesia, Spinal; Headache; Humans; Male; Sumatriptan

1995
Another complication of the combined extradural-subarachnoid technique.
    British journal of anaesthesia, 1995, Volume: 75, Issue:3

    Topics: Adult; Anesthesia, Epidural; Anesthesia, Obstetrical; Anesthesia, Spinal; Cesarean Section; Female;

1995
Health-related quality of life in headache research.
    Headache, 1995, Volume: 35, Issue:8

    Topics: Headache; Health Status; Humans; Longitudinal Studies; Quality of Life; Sumatriptan

1995
SUNCT syndrome.
    The Medical journal of Australia, 1995, Jun-19, Volume: 162, Issue:12

    Topics: Adult; Aged; Conjunctival Diseases; Ergotamine; Female; Headache; Humans; Male; Sumatriptan; Syndrom

1995
Sumatriptan and daily headache.
    Journal of neurology, neurosurgery, and psychiatry, 1995, Volume: 58, Issue:4

    Topics: Headache; Humans; Sumatriptan; Time Factors

1995
[Headache caused by analgesics].
    Nederlands tijdschrift voor geneeskunde, 1994, Dec-24, Volume: 138, Issue:52

    Topics: Acetaminophen; Adult; Female; Headache; Humans; Middle Aged; Migraine Disorders; Sumatriptan

1994
Ergotamine-induced headache can be sustained by sumatriptan daily intake.
    Cephalalgia : an international journal of headache, 1994, Volume: 14, Issue:5

    Topics: Adult; Ergotamine; Female; Headache; Humans; Sumatriptan

1994
Sumatriptan for high-altitude headache.
    Lancet (London, England), 1994, Nov-19, Volume: 344, Issue:8934

    Topics: Adult; Altitude Sickness; Female; Headache; Humans; Male; Middle Aged; Migraine Disorders; Sumatript

1994
Effects of the serotonin-receptor agonist sumatriptan on postdural puncture headache: report of six cases.
    Anesthesia and analgesia, 1994, Volume: 79, Issue:1

    Topics: Adult; Anesthesia, Epidural; Anesthesia, Spinal; Female; Headache; Humans; Male; Pregnancy; Spinal P

1994
Sumatriptan and giant cell arteritis.
    Journal of neurology, neurosurgery, and psychiatry, 1994, Volume: 57, Issue:5

    Topics: Aged; Female; Giant Cell Arteritis; Headache; Humans; Sumatriptan

1994
Transient resolution of headache in giant cell temporal arteritis after sumatriptan.
    Cephalalgia : an international journal of headache, 1993, Volume: 13, Issue:6

    Topics: Aged; Female; Giant Cell Arteritis; Headache; Humans; Sumatriptan; Time Factors

1993
Subcutaneous sumatriptan in the treatment of acute episodes of posttraumatic headache.
    Headache, 1993, Volume: 33, Issue:2

    Topics: Adult; Female; Headache; Humans; Indoles; Injections, Subcutaneous; Male; Serotonin Receptor Agonist

1993
Coexistence of migraine and idiopathic intracranial hypertension without papilledema.
    Neurology, 1996, Volume: 46, Issue:5

    Topics: Acetazolamide; Adolescent; Adult; Dihydroergotamine; Diuretics; Ergotamine; Female; Follow-Up Studie

1996
Easy therapeutical management of sumatriptan-induced daily headache.
    Neurology, 1996, Volume: 47, Issue:1

    Topics: Adult; Aged; Female; Headache; Humans; Middle Aged; Sumatriptan; Time Factors

1996
[Limits of sumatriptan in the treatment of headache after dura mater puncture].
    Annales francaises d'anesthesie et de reanimation, 1996, Volume: 15, Issue:2

    Topics: Adult; Anesthesia, Epidural; Anesthesia, Obstetrical; Blood Patch, Epidural; Dura Mater; Female; Hea

1996
Amitriptyline and dexamethasone combined treatment in drug-induced headache.
    Cephalalgia : an international journal of headache, 1996, Volume: 16, Issue:3

    Topics: Adult; Amitriptyline; Analgesics; Dexamethasone; Drug Therapy, Combination; Female; Headache; Humans

1996
Participation of 5-HT1-like and 5-HT2A receptors in the contraction of human temporal artery by 5-hydroxytryptamine and related drugs.
    British journal of pharmacology, 1996, Volume: 117, Issue:2

    Topics: Adult; Aged; Benzazepines; Collagenases; Endothelium, Vascular; Female; Headache; Humans; In Vitro T

1996
Headache recurrence.
    Cephalalgia : an international journal of headache, 1996, Volume: 16, Issue:4

    Topics: Headache; Humans; Recurrence; Sumatriptan

1996
Risk factors for headache recurrence after sumatriptan: a study in 366 migraine patients.
    Cephalalgia : an international journal of headache, 1996, Volume: 16, Issue:4

    Topics: Adult; Female; Headache; Humans; Male; Middle Aged; Prognosis; Recurrence; Risk Factors; Sumatriptan

1996
Nitroglycerin-induced headache.
    Cephalalgia : an international journal of headache, 1996, Volume: 16, Issue:6

    Topics: Arteriovenous Anastomosis; Dose-Response Relationship, Drug; Head; Headache; Humans; Migraine Disord

1996
Prescribing practices for the management of headache in Newfoundland and Labrador.
    Headache, 1996, Volume: 36, Issue:9

    Topics: Analgesics; Cohort Studies; Drug Prescriptions; Headache; Humans; Migraine Disorders; Newfoundland a

1996
Sumatriptan: an alternative to epidural blood patch?
    Anaesthesia, 1996, Volume: 51, Issue:11

    Topics: Anesthesia, Epidural; Anesthesia, Obstetrical; Blood Patch, Epidural; Female; Headache; Humans; Sero

1996
Cognitive processing in primary headache: a study on event-related potentials.
    Neurology, 1997, Volume: 48, Issue:1

    Topics: Adolescent; Adult; Aged; Cluster Headache; Cognition; Evoked Potentials; Female; Habituation, Psycho

1997
The use of sumatriptan in the treatment of postdural puncture headache.
    Anaesthesia, 1997, Volume: 52, Issue:8

    Topics: Adult; Anesthesia, Spinal; Dura Mater; Female; Headache; Humans; Serotonin Receptor Agonists; Sumatr

1997
Sumatriptan and postdural puncture headache.
    Anaesthesia, 1997, Volume: 52, Issue:11

    Topics: Blood Patch, Epidural; Dura Mater; Headache; Humans; Sumatriptan; Vasoconstrictor Agents

1997
[Failure of sumatriptan in post-dural puncture headache].
    Revista espanola de anestesiologia y reanimacion, 1997, Volume: 44, Issue:9

    Topics: Adult; Anesthesia, Epidural; Female; Headache; Humans; Serotonin Receptor Agonists; Sumatriptan

1997
Chronic paroxysmal hemicrania and hemicrania continua: lack of efficacy of sumatriptan.
    Headache, 1998, Volume: 38, Issue:3

    Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Dosage Forms; Female; Headach

1998
Inappropriate use of sumatriptan: population based register and interview study.
    BMJ (Clinical research ed.), 1998, May-02, Volume: 316, Issue:7141

    Topics: Adult; Chronic Disease; Denmark; Female; Headache; Health Services Misuse; Humans; Male; Middle Aged

1998
Successful treatment of headache related to intravenous immunoglobulin with antimigraine medications.
    Headache, 1998, Volume: 38, Issue:4

    Topics: Adult; Analgesics, Non-Narcotic; Dihydroergotamine; Female; Headache; Humans; Immunoglobulins, Intra

1998
Sumatriptan was effective in electroconvulsive therapy (ECT) headache.
    Anesthesiology, 1998, Volume: 89, Issue:5

    Topics: Electroconvulsive Therapy; Headache; Humans; Serotonin Receptor Agonists; Sumatriptan

1998
Sumatriptan for post-ECT headache.
    The journal of ECT, 1998, Volume: 14, Issue:4

    Topics: Administration, Oral; Adult; Depressive Disorder; Electroconvulsive Therapy; Female; Headache; Human

1998
A triptan too far?
    Journal of neurology, neurosurgery, and psychiatry, 1999, Volume: 66, Issue:1

    Topics: Headache; Humans; Oxazoles; Oxazolidinones; Serotonin Receptor Agonists; Sumatriptan; Tryptamines

1999
A triptan too far?
    Journal of neurology, neurosurgery, and psychiatry, 1999, Volume: 66, Issue:1

    Topics: Headache; Humans; Oxazoles; Oxazolidinones; Serotonin Receptor Agonists; Sumatriptan; Tryptamines

1999
The use of sumatriptan in the treatment of postdural puncture headache after accidental lumbar puncture complicated a blood patch procedure.
    Anaesthesia, 1999, Volume: 54, Issue:1

    Topics: Adult; Analgesia, Epidural; Analgesia, Obstetrical; Blood Patch, Epidural; Female; Headache; Humans;

1999
Drug-induced headaches.
    Lancet (London, England), 1999, Jul-17, Volume: 354, Issue:9174

    Topics: Analgesics, Non-Narcotic; Ergotamine; Headache; Humans; Indoles; Oxazoles; Oxazolidinones; Piperidin

1999
Open-labeled long-term study of the efficacy, safety, and tolerability of subcutaneous sumatriptan in acute migraine treatment.
    Cephalalgia : an international journal of headache, 1999, Volume: 19, Issue:7

    Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Analgesics; Antiemetics; Calcium Channel Block

1999
Headache in Meniere's disease.
    Auris, nasus, larynx, 1999, Volume: 26, Issue:4

    Topics: Adult; Aged; Amitriptyline; Analgesics, Non-Narcotic; Antidepressive Agents, Tricyclic; Carbamazepin

1999
Alteration in nature of cluster headache during subcutaneous administration of sumatriptan.
    Headache, 2000, Volume: 40, Issue:1

    Topics: Adult; Chronic Disease; Cluster Headache; Headache; Humans; Injections, Subcutaneous; Male; Middle A

2000
Headache relief after sumatriptan in a patient with pituitary macroadenoma.
    Headache, 2000, Volume: 40, Issue:5

    Topics: Adenoma, Chromophobe; Adult; Female; Headache; Humans; Pituitary Neoplasms; Sumatriptan

2000
[Hemicranial headache caused by orbital cellulitis successfully treated with sumatriptan].
    Anales de medicina interna (Madrid, Spain : 1984), 2000, Volume: 17, Issue:5

    Topics: Adult; Cellulitis; Headache; Humans; Male; Orbital Diseases; Remission Induction; Serotonin Receptor

2000
Vestibular schwannoma surgery and headache.
    Acta oto-laryngologica. Supplementum, 2000, Volume: 543

    Topics: Adult; Aged; Anesthetics, Local; Dizziness; Female; Follow-Up Studies; Headache; Humans; Lidocaine;

2000
Management of a septic patient with postdural puncture headache.
    Anaesthesia, 2000, Volume: 55, Issue:7

    Topics: Adult; Blood Patch, Epidural; Contraindications; Dura Mater; Female; Headache; Humans; Sepsis; Serot

2000
A comment on time-to-event analysis for headache relief.
    Cephalalgia : an international journal of headache, 2000, Volume: 20, Issue:4

    Topics: Analgesics; Headache; Humans; Indoles; Oxazolidinones; Piperidines; Randomized Controlled Trials as

2000
Sumatriptan for headache caused by head and neck cancer.
    Headache, 2000, Volume: 40, Issue:9

    Topics: Adult; Aged; Carcinoma; Carcinoma, Squamous Cell; Fatal Outcome; Head and Neck Neoplasms; Headache;

2000
Dramatic headache relief after sumatriptan in a patient with a pituitary macroadenoma.
    Headache, 1999, Volume: 39, Issue:6

    Topics: Adenoma; Adult; Female; Headache; Humans; Injections, Subcutaneous; Pituitary Neoplasms; Sumatriptan

1999
Headache due to antimigraine 5HT1 receptor agonists.
    Prescrire international, 1999, Volume: 8, Issue:44

    Topics: Analgesics; Headache; Headache Disorders; Humans; Indoles; Oxazolidinones; Piperidines; Prospective

1999
Criteria for use of sumatriptan in adult inpatients and outpatients.
    Clinical pharmacy, 1992, Volume: 11, Issue:11

    Topics: Adult; Ambulatory Care; Headache; Humans; Indoles; Inpatients; Sulfonamides; Sumatriptan; Vasoconstr

1992
Headache recurrence after subcutaneous sumatriptan and early treatment.
    Lancet (London, England), 1992, Oct-10, Volume: 340, Issue:8824

    Topics: Adult; Female; Headache; Humans; Indoles; Injections, Subcutaneous; Male; Middle Aged; Recurrence; S

1992
Serotonin receptors and headache.
    The New England journal of medicine, 1991, Aug-01, Volume: 325, Issue:5

    Topics: Cluster Headache; Headache; Humans; Indoles; Migraine Disorders; Receptors, Serotonin; Sulfonamides;

1991